Biological activity of chemically synthesized core sugar linked lipid A analog, heptose-(alpha 1----5)-2-keto-3-deoxyoctonic acid-(alpha 2----6)-2,3-diacyloxyacylglucosamine-4-phosphate

Int J Immunopharmacol. 1992 Feb;14(2):221-6. doi: 10.1016/0192-0561(92)90034-i.

Abstract

The mitogenicity, lethal toxicity and antitumor activity against Meth A fibrosarcoma and the induction of tumor necrosis factor (TNF) of chemically synthesized compounds designated as A-103, 2,3-diacyloxyacylglucosamine-4-phosphate (GlcN-4-P), and A-503), heptose-(alpha 1----5)-2-keto-3-deoxyoctonic acid (KDO)-linked GlcN-4-P (A-103), were determined. Compound A-103 induced significant incorporation of [3H]thymidine of C57BL/6 mice at 25-100 micrograms/ml, and A-503 showed the highest incorporation of [3H]thymidine at 100 micrograms/ml. The mitogenicity of A-503 exhibited a lower activity than of A-103. Compound A-503 showed no lethality at high doses of 25 and 50 micrograms/mouse in C57BL/6 mice loaded with D-galactosamine, whereas A-103 caused the death of one of three mice at a dose of 50 micrograms/mouse. Although, the two compounds with or without muramyl dipeptide showed weak antitumor activity against Meth A fibrosarcoma in BALB/c mice, but there were no remarkable differences between the compounds on antitumor activity. Peritoneal macrophages, stimulated with A-103 or A-503 caused no production of TNF which induces L929 cell lysis in vitro. These findings indicate that the addition of heptose and KDO to GlcN-4-P seems not to affect mitogenic activity, lethal toxicity, antitumor activity and TNF-production of the GlcN-4-P compound (A-103).

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology
  • Lipid A / analogs & derivatives*
  • Lipid A / pharmacology
  • Lipid A / toxicity
  • Lipopolysaccharides
  • Male
  • Mice
  • Mice, Inbred Strains
  • Mitogens / pharmacology
  • Structure-Activity Relationship
  • Tumor Necrosis Factor-alpha / biosynthesis

Substances

  • Antineoplastic Agents
  • Lipid A
  • Lipopolysaccharides
  • Mitogens
  • Tumor Necrosis Factor-alpha
  • A 503